» Articles » PMID: 20496895

Multiple N-methylation of MT-II Backbone Amide Bonds Leads to Melanocortin Receptor Subtype HMC1R Selectivity: Pharmacological and Conformational Studies

Overview
Journal J Am Chem Soc
Specialty Chemistry
Date 2010 May 26
PMID 20496895
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple N-methylation is a novel technology to improve bioavailability of peptides and increase receptor subtype selectivity. This technique has been applied here to the superpotent but nonselective cyclic peptide MT-II. A library of all possible 31 backbone N-methylated derivatives has been synthesized and tested for binding and activation at melanocortin receptor subtypes 1, 3, 4, and 5. It turned out that selectivity is improved with every introduced N-methyl group, resulting in several N-methylated selective and potent agonists for the hMC1R. The most potent of these derivatives is N-methylated on four out of five amide bonds in the cyclic structure. Its solution structure indicates a strongly preferred backbone conformation that resembles other alpha-MSH analogs but possesses much less flexibility and in addition distinct differences in the spatial arrangement of individual amino acid side chains.

Citing Articles

Hepatocyte-specific loss of melanocortin 1 receptor disturbs fatty acid metabolism and promotes adipocyte hypertrophy.

Thapa K, Ghimire B, Pokharel K, Cai M, Savontaus E, Rinne P Int J Obes (Lond). 2024; 48(11):1625-1637.

PMID: 39117851 PMC: 11502480. DOI: 10.1038/s41366-024-01600-9.


Synthesis of Cyclopeptides Analogues of Natural Products and Evaluation as Herbicides and Inhibitors of Cyanobacteria.

Irabuena C, Posada L, Colombo S, Aubriot L, Rey L, Villalba J ACS Omega. 2024; 9(18):20167-20175.

PMID: 38737041 PMC: 11079878. DOI: 10.1021/acsomega.4c00311.


α-Melanocyte-stimulating hormone alleviates pathological cardiac remodeling via melanocortin 5 receptor.

Suominen A, Saldo Rubio G, Ruohonen S, Szabo Z, Pohjolainen L, Ghimire B EMBO Rep. 2024; 25(4):1987-2014.

PMID: 38454158 PMC: 11014855. DOI: 10.1038/s44319-024-00109-6.


Melanocortin 1 receptor regulates cholesterol and bile acid metabolism in the liver.

Thapa K, Kadiri J, Saukkonen K, Pennanen I, Ghimire B, Cai M Elife. 2023; 12.

PMID: 37490042 PMC: 10368426. DOI: 10.7554/eLife.84782.


Ribosomal incorporation of negatively charged d-α- and -methyl-l-α-amino acids enhanced by EF-Sep.

Katoh T, Suga H Philos Trans R Soc Lond B Biol Sci. 2023; 378(1871):20220038.

PMID: 36633283 PMC: 9835608. DOI: 10.1098/rstb.2022.0038.


References
1.
van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark A, Berendsen H . GROMACS: fast, flexible, and free. J Comput Chem. 2005; 26(16):1701-18. DOI: 10.1002/jcc.20291. View

2.
King S, Mayorov A, Balse-Srinivasan P, Hruby V, Vanderah T, Wessells H . Melanocortin receptors, melanotropic peptides and penile erection. Curr Top Med Chem. 2007; 7(11):1098-1106. PMC: 2694735. View

3.
Xia Y, Wikberg J . Localization of ACTH receptor mRNA by in situ hybridization in mouse adrenal gland. Cell Tissue Res. 1996; 286(1):63-8. DOI: 10.1007/s004410050675. View

4.
Mayorov A, Han S, Cai M, Hammer M, Trivedi D, Hruby V . Effects of macrocycle size and rigidity on melanocortin receptor-1 and -5 selectivity in cyclic lactam alpha-melanocyte-stimulating hormone analogs. Chem Biol Drug Des. 2006; 67(5):329-35. PMC: 1851940. DOI: 10.1111/j.1747-0285.2006.00383.x. View

5.
Ying J, Kover K, Gu X, Han G, Trivedi D, Kavarana M . Solution structures of cyclic melanocortin agonists and antagonists by NMR. Biopolymers. 2004; 71(6):696-716. DOI: 10.1002/bip.10596. View